Published in Curr Neuropharmacol on September 01, 2007
Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev (2010) 1.89
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders. Nat Rev Drug Discov (2014) 1.51
Molecular basis for amino acid sensing by family C G-protein-coupled receptors. Br J Pharmacol (2009) 1.25
Functioning of the dimeric GABA(B) receptor extracellular domain revealed by glycan wedge scanning. EMBO J (2008) 1.14
Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets. Diabetes (2010) 1.14
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. Chem Rev (2016) 0.97
GABAB receptor-positive modulators: brain region-dependent effects. J Pharmacol Exp Ther (2011) 0.85
GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo. J Pharmacol Exp Ther (2010) 0.84
Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization. Alcohol (2012) 0.83
ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder. Br J Pharmacol (2014) 0.82
Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats. Psychopharmacology (Berl) (2016) 0.81
Regulating hippocampal hyperexcitability through GABAB Receptors. Physiol Rep (2014) 0.78
GABAB receptor upregulates fragile X mental retardation protein expression in neurons. Sci Rep (2015) 0.78
The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats. Neuropsychopharmacology (2017) 0.77
A Role for Diminished GABA Transporter Activity in the Cortical Discharge Phenotype of MeCP2-Deficient Mice. Neuropsychopharmacology (2015) 0.75
Influence of leptin and GABAB-receptor agonist and antagonist on neurons of the hypothalamic infundibular nucleus in the chicken. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2017) 0.75
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (2000) 6.58
Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature (1998) 5.59
GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature (1998) 5.03
GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature (1998) 4.33
A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron (2000) 3.98
Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem (2003) 3.90
3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain. Nature (1981) 3.55
Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther (2003) 3.36
Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature (1997) 3.22
Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+. Proc Natl Acad Sci U S A (2002) 2.75
Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron (2006) 2.53
Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron (2001) 2.51
Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol (2001) 2.32
Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J (2001) 2.28
A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol Pharmacol (2003) 2.27
Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1alpha. Nat Struct Mol Biol (2004) 2.18
International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev (2002) 2.15
C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J Neurosci (2001) 1.90
Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci (2005) 1.84
Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc Natl Acad Sci U S A (2001) 1.84
Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology (2004) 1.72
Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J (2005) 1.72
Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J (2006) 1.66
Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Mol Cell Neurosci (2001) 1.58
Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr Opin Pharmacol (2002) 1.58
A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor. J Biol Chem (2001) 1.49
The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J Neurosci (2001) 1.48
The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. J Biol Chem (2004) 1.45
Compartment-dependent colocalization of Kir3.2-containing K+ channels and GABAB receptors in hippocampal pyramidal cells. J Neurosci (2006) 1.45
Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther (2004) 1.45
BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol Pharmacol (2001) 1.41
GABAB receptor: a site of therapeutic benefit. Curr Opin Pharmacol (2005) 1.38
GABA(B2) is essential for g-protein coupling of the GABA(B) receptor heterodimer. J Neurosci (2001) 1.37
No ligand binding in the GB2 subunit of the GABA(B) receptor is required for activation and allosteric interaction between the subunits. J Neurosci (2002) 1.36
N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J Pharmacol Exp Ther (2003) 1.36
Activation mechanism of the heterodimeric GABA(B) receptor. Biochem Pharmacol (2004) 1.34
Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci (2003) 1.34
Intracellular retention of recombinant GABAB receptors. J Biol Chem (1998) 1.33
Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacol Ther (2006) 1.30
The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology (2006) 1.28
GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend (2002) 1.27
Locking the dimeric GABA(B) G-protein-coupled receptor in its active state. J Neurosci (2004) 1.25
The N-terminal domain of gamma-aminobutyric Acid(B) receptors is sufficient to specify agonist and antagonist binding. Mol Pharmacol (1999) 1.24
Ca(2+) requirement for high-affinity gamma-aminobutyric acid (GABA) binding at GABA(B) receptors: involvement of serine 269 of the GABA(B)R1 subunit. Mol Pharmacol (2000) 1.19
Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology (1999) 1.18
A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol (2002) 1.17
Mapping the agonist-binding site of GABAB type 1 subunit sheds light on the activation process of GABAB receptors. J Biol Chem (2000) 1.16
Assembly-dependent surface targeting of the heterodimeric GABAB Receptor is controlled by COPI but not 14-3-3. Mol Biol Cell (2005) 1.15
Coupling of agonist binding to effector domain activation in metabotropic glutamate-like receptors. J Biol Chem (2006) 1.14
Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors. J Biol Chem (2007) 1.13
SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem Pharmacol (2004) 1.10
Calcium sensing properties of the GABA(B) receptor. Neuropharmacology (1999) 1.09
The intracellular loops of the GB2 subunit are crucial for G-protein coupling of the heteromeric gamma-aminobutyrate B receptor. Mol Pharmacol (2002) 1.08
The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology (2005) 1.02
Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology (Berl) (2004) 1.02
Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties. Neuropharmacology (2005) 1.01
A model for the functioning of family 3 GPCRs. Trends Pharmacol Sci (2002) 0.99
Demonstration of a tandem pair of complement protein modules in GABA(B) receptor 1a. FEBS Lett (1998) 0.98
GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology (2006) 0.97
Reducing effect of the positive allosteric modulators of the GABA(B) receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. Eur J Pharmacol (2005) 0.97
Pharmacology of absence epilepsy. Trends Pharmacol Sci (2003) 0.91
In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor. Eur J Pharmacol (2004) 0.87
Point mutations in the transmembrane region of GABAB2 facilitate activation by the positive modulator N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the absence of the GABAB1 subunit. Mol Pharmacol (2006) 0.87
GABA(B) receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area. Br J Pharmacol (2005) 0.86
Differential modulation by the GABAB receptor allosteric potentiator 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) of synaptic transmission in the rat hippocampal CA1 area. J Pharmacol Exp Ther (2006) 0.85
The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo. J Neurochem (2006) 0.83
Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain. Neurochem Res (2003) 0.83
Point mutations in either subunit of the GABAB receptor confer constitutive activity to the heterodimer. Mol Pharmacol (2006) 0.82
Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity. Drugs (1974) 0.82
Potentiation of metabotropic GABAB receptors by L-amino acids and dipeptides in rat neocortex. Eur J Pharmacol (2003) 0.81
Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors. Eur J Pharmacol (2004) 0.80
Characterization of the binding of [3H]CGP54626 to GABAB receptors in the male bullfrog (Rana catesbeiana). Brain Res (2006) 0.80
Positive regulation of GABA(B) receptors dually coupled to cyclic AMP by the allosteric agent CGP7930. Eur J Pharmacol (2003) 0.80
Arylalkylamines are a novel class of positive allosteric modulators at GABA(B) receptors in rat neocortex. Eur J Pharmacol (2002) 0.79
Allosteric modulation of GABA(B) receptor function in human frontal cortex. Neurochem Int (2005) 0.76
Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther (2003) 3.36
Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods (2008) 2.88
Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol (2004) 2.58
Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J (2005) 1.72
Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators. J Biol Chem (2005) 1.55
A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor. J Biol Chem (2001) 1.49
Dimers and beyond: The functional puzzles of class C GPCRs. Pharmacol Ther (2011) 1.48
The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. J Biol Chem (2004) 1.45
Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. Proc Natl Acad Sci U S A (2003) 1.44
Activation mechanism of the heterodimeric GABA(B) receptor. Biochem Pharmacol (2004) 1.34
Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. EMBO J (2009) 1.32
Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol Pharmacol (2007) 1.17
Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors. J Biol Chem (2007) 1.13
The oligomeric state sets GABA(B) receptor signalling efficacy. EMBO J (2011) 1.05
A model for the functioning of family 3 GPCRs. Trends Pharmacol Sci (2002) 0.99
The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptors. Neuropharmacology (2010) 0.96
The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation. Biochem J (2010) 0.95
The second intracellular loop of metabotropic glutamate receptors recognizes C termini of G-protein alpha-subunits. J Biol Chem (2003) 0.89
Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to G protein-coupled receptor oligomerization. Methods Mol Biol (2011) 0.84
Among the twenty classical L-amino acids, only glutamate directly activates metabotropic glutamate receptors. Neuropharmacology (2005) 0.83
Further insights into GPR179: expression, localization, and associated pathogenic mechanisms leading to complete congenital stationary night blindness. Invest Ophthalmol Vis Sci (2013) 0.81
Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. Mol Cell Proteomics (2014) 0.79
Amino-pyrrolidine tricarboxylic acids give new insight into group III metabotropic glutamate receptor activation mechanism. Mol Pharmacol (2006) 0.77
Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling. AIDS (2017) 0.75
Time-resolved Förster resonance energy transfer-based technologies to investigate G protein-coupled receptor machinery: high-throughput screening assays and future development. Prog Mol Biol Transl Sci (2013) 0.75